Exome Sequencing Market The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing – despite price declines – has led to demands for more efficient methods. Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual's DNA that provide instructions for making proteins are sequenced. These pieces, called exons, are thought to make up roughly 2 percent of a person's genome. Because most known mutations that cause disease occur in exons, whole exome sequencing is thought to be an efficient method to identify possible disease-causing mutations. Exome Sequencing Market provides the following data:
- Exome Sequencing Market, 2019-2024
- Exome Sequencing Market by Region, 2019 (%; US, Europe, ROW)
- Executive Summary
- Demand for Effectiveness
- Selected Products on the Market
- Table Selected Exome Sequencing Kits
- Challenges, Possible Disruption in the Market
- WGS/WES Comparison
- Table Cost per Human Genome, 2001 to 2019 – NIH
- Size and Growth of the Market
- Exome Sequencing Recent Developments
- Exome Sequencing Market
- Products on the Market
- Table Sequencers Used In Exome Sequencing
- Application Forecast of Exome Sequencing: End Users
- Table Applications Expected to Increase the Most, 2019
- Table Applications Expected to Increase the Most – Change between 2017 and 2019
- Size and Growth of the Market
- Table Exome Sequencing Market, 2019-2024
- Regional Market
- Table Exome Sequencing Market by Region, 2019 (%; US, Europe, ROW)
- Products on the Market
- Company Profiles
- 10X Genomics
- Agilent Technologies
- BGI Genomics (formerly Beijing Genome Institute)
- Illumina
- Oxford Nanopore
- Qiagen N.V.
- Roche Diagnostics
- Thermo Fisher Scientific Inc.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook